View all results
Noticia de prueba
16 November 2023
Almirall receives European Commission approval of EBGLYSS® (lebrikizumab) for moderate-to-severe atopic dermatitis
11 October 2023
test cron global
25 May 2022
Almirall launches the innovative Wynzora® cream in Denmark for the treatment of mild to moderate plaque psoriasis including scalp in adults
View all press
We are going to take you to a different platform
This platform is safe as takes part of Almirall ecosystem
You are about to leave www.almirall.com
Specific policies may apply to the site you are visiting; all interaction with that site is at your own risk.
The content you are about to see is restricted to media professional use
Please let us know if you are a professional to continue.
I'm a media professional
The content you are about to see is restricted to HC Professional use only
Please let us know if you are a HC Professional to continue.
I'm a HC Professional